The global Bifidobacterium Probiotics Market Comprehensive Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments -By Type (Liquid, Powder), By Application (Food & Beverage, Drugs, Dietary Supplements, Others)
In 2024, the Bifidobacterium Probiotics market is witnessing significant growth, driven by the increasing awareness of the health benefits associated with probiotics. Bifidobacterium probiotics are valued for their role in promoting gut health, boosting the immune system, and improving overall well-being. The market is supported by the growing consumer interest in functional foods and dietary supplements that offer health benefits beyond basic nutrition. Advances in probiotic research and formulation technologies are enhancing the stability, efficacy, and delivery of Bifidobacterium probiotics. The market is also benefiting from the trend towards natural and preventive health solutions, appealing to health-conscious consumers seeking to improve their digestive health and overall wellness.
The market report analyses the leading companies in the industry including BioGaia, China-Biotics, Chr. Hansen, Danone S.A., DuPont de Nemours Inc, Lallemand, Nestlé S.A., Novozymes A/S, Probi, Yakult, and Others.
The most prominent market trend for Bifidobacterium Probiotics is the growing consumer awareness and demand for probiotics. Probiotics, including Bifidobacterium strains, are gaining popularity due to their potential health benefits, such as improving gut health, boosting immunity, and supporting overall well-being. Consumers are increasingly seeking functional foods and beverages that contain probiotics, driven by the desire for digestive health, immune system support, and a holistic approach to wellness. This trend reflects a broader shift towards preventive healthcare and proactive management of gut-related issues, fueling the demand for Bifidobacterium probiotics in various product formulations.
A key market driver for Bifidobacterium Probiotics is the focus on gut health and wellness trends. Scientific research highlighting the role of gut microbiota in maintaining overall health has led to increased interest in probiotics, particularly Bifidobacterium strains known for their ability to thrive in the human gut environment. The growing recognition of gut-brain axis communication, the importance of a balanced microbiome, and the link between gut health and immune function are driving consumers and healthcare professionals to seek probiotic-rich products. The driver of gut health and wellness trends propels the demand for Bifidobacterium probiotics as essential components in functional foods, dietary supplements, and probiotic beverages.
A potential opportunity within the Bifidobacterium Probiotics market lies in the expansion into diverse product categories and formulations. Collaborating with food and beverage manufacturers to incorporate Bifidobacterium strains into a wide range of products, including yogurt, fermented foods, probiotic drinks, snacks, and dietary supplements, can broaden market reach and appeal to diverse consumer preferences. Furthermore, exploring innovative formulations, such as microencapsulation for improved probiotic survival, targeted delivery systems, and combination products with prebiotics or other functional ingredients, can enhance product efficacy and consumer acceptance. By leveraging opportunities to expand into diverse product categories and formulations, there are prospects to capitalize on the growing demand for Bifidobacterium probiotics, differentiate products in the market, and meet evolving consumer needs for gut health and wellness.
In the Bifidobacterium Probiotics Market, the largest segment is Powder. Powdered bifidobacterium probiotics are widely used and preferred by consumers due to their convenience, versatility, and longer shelf life compared to liquid forms. The fast growth of the powder segment can be attributed to several factors. Firstly, powdered probiotics can be easily incorporated into various food and beverage products, such as yogurt, smoothies, and baked goods, making them a popular choice for consumers looking to boost their digestive health. Additionally, powdered probiotics are often available in a wider range of formulations, concentrations, and strains, allowing consumers to choose products that best suit their specific health needs. The convenience of powdered probiotics for storage, travel, and daily consumption also contributes to their popularity among health-conscious individuals. As a result, the Powder segment continues to dominate the Bifidobacterium Probiotics Market and is expected to maintain strong growth in the coming years.
Within the Bifidobacterium Probiotics Market, the Dietary Supplements segment is anticipated to be the fastest growing up to 2032. Bifidobacterium probiotics in dietary supplements are experiencing rapid growth due to several key factors. Firstly, there is a growing awareness and interest among consumers in maintaining gut health and overall well-being, leading to increased demand for probiotic supplements containing bifidobacterium strains. These supplements offer a convenient and effective way for individuals to incorporate probiotics into their daily routine, especially for those who may not consume probiotic-rich foods regularly. Additionally, the rising prevalence of digestive issues, immune system concerns, and the desire for natural health solutions are driving consumers towards probiotic dietary supplements. The Dietary Supplements segment is also benefiting from advancements in probiotic research, formulation technologies, and product innovation, leading to a diverse range of probiotic supplements tailored to different health needs. As a result, the Dietary Supplements segment in the Bifidobacterium Probiotics Market is expected to experience significant growth and opportunities in the coming years.
By Type
Liquid
Powder
By Application
Food & Beverage
Drugs
Dietary Supplements
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
BioGaia
China-Biotics
Chr. Hansen
Danone S.A.
DuPont de Nemours Inc
Lallemand
Nestlé S.A.
Novozymes A/S
Probi
Yakult
*- List Not Exhaustive
Chapter 1. TABLE OF CONTENTS
Chapter 2. Introduction to Bifidobacterium Probiotics Market
2.1. Market Overview
2.2. Key Statistics and Report Highlights
2.3. Scope of the Comprehensive Study
2.3.1. Market Definition
2.3.2 Countries and Regions Covered
2.3.3 Research Objective
2.3.4 Units, Currency, and Conversions
2.3.5 Industry Value Chain
2.4. Key Market Segments
2.5. Key Companies
2.6. Study Period
Chapter 3. Strategic Analysis Review
3.1. Bifidobacterium Probiotics Pricing Analysis and Forecast
3.2. Porter’s Five Forces
3.3. Market Ecosystem
3.4. SWOT Analysis
3.5. Regulatory Scenario
3.3. Effects of Inflation, Russia-Ukraine War, moderating economic growth, and other macroeconomic factors
Chapter 4. Competitive Landscape
4.1. Market Share Analysis
4.1.1. Global Bifidobacterium Probiotics Market Share by Company, 2023
4.1.2. Product Offerings of Leading Bifidobacterium Probiotics Companies
4.2. Market Entropy
4.2.1. New Product Launches in the Industry
4.2.2. Mergers, Acquisitions, Joint ventures, and Partnerships
4.3. Key Strategies and Best Practices
Chapter 5. Global Market Projections: Best, Reference, and Low Case Scenarios
5.1. Growth Analysis- Case Scenario Definitions
5.2. Low Growth Case Scenario Forecasts
5.3. Reference Growth Case Scenario Forecasts
5.4. High Growth Case Scenario Forecasts
Chapter 6. Market Dynamics
6.1. Bifidobacterium Probiotics Market Drivers
6.2. Bifidobacterium Probiotics Market Challenges
6.6. Bifidobacterium Probiotics Market Opportunities
6.4. Bifidobacterium Probiotics Market Trends
Chapter 7. Global Bifidobacterium Probiotics Market Outlook Trends
7.1. Global Bifidobacterium Probiotics Revenue (USD Million) and CAGR (%) by Type (2021-2032)
7.2. Global Bifidobacterium Probiotics Revenue (USD Million) and CAGR (%) by Application (2021-2032)
7.3. Global Bifidobacterium Probiotics Revenue (USD Million) and CAGR (%) by Product (2021-2032)
By Type
Liquid
Powder
By Application
Food & Beverage
Drugs
Dietary Supplements
Others
Chapter 8. Global Bifidobacterium Probiotics Regional Analysis and Outlook
8.1. Global Bifidobacterium Probiotics Revenue (USD Million) By Regions (2021- 2032)
8.2. North America Bifidobacterium Probiotics Revenue (USD Million) by Country (2021-2032)
8.2.1. United States Bifidobacterium Probiotics Regional Analysis and Outlook
8.2.2. Canada Bifidobacterium Probiotics Regional Analysis and Outlook
8.2.3. Mexico Bifidobacterium Probiotics Regional Analysis and Outlook
8.3. Europe Bifidobacterium Probiotics Revenue (USD Million), by Country (2021-2032)
8.3.1. Germany Bifidobacterium Probiotics Regional Analysis and Outlook
8.3.2. France Bifidobacterium Probiotics Regional Analysis and Outlook
8.3.3. United Kingdom Bifidobacterium Probiotics Regional Analysis and Outlook
8.3.4. Spain Bifidobacterium Probiotics Regional Analysis and Outlook
8.3.5. Italy Bifidobacterium Probiotics Regional Analysis and Outlook
8.3.6. Russia Bifidobacterium Probiotics Regional Analysis and Outlook
8.3.7. Rest of Europe Bifidobacterium Probiotics Regional Analysis and Outlook
8.4. Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) by Country (2021-2032)
8.4.1. China Bifidobacterium Probiotics Regional Analysis and Outlook
8.4.2. Japan Bifidobacterium Probiotics Regional Analysis and Outlook
8.4.3. India Bifidobacterium Probiotics Regional Analysis and Outlook
8.4.4. South Korea Bifidobacterium Probiotics Regional Analysis and Outlook
8.4.5. Australia Bifidobacterium Probiotics Regional Analysis and Outlook
8.4.6. South East Asia Bifidobacterium Probiotics Regional Analysis and Outlook
8.4.7. Rest of Asia Pacific Bifidobacterium Probiotics Regional Analysis and Outlook
8.5. South America Bifidobacterium Probiotics Revenue (USD Million), by Country (2021-2032)
8.5.1. Brazil Bifidobacterium Probiotics Regional Analysis and Outlook
8.5.2. Argentina Bifidobacterium Probiotics Regional Analysis and Outlook
8.5.3. Rest of South America Bifidobacterium Probiotics Regional Analysis and Outlook
8.6. Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) by Country (2021-2032)
8.6.1. Middle East Bifidobacterium Probiotics Regional Analysis and Outlook
8.6.2. Africa Bifidobacterium Probiotics Regional Analysis and Outlook
Chapter 9. North America Bifidobacterium Probiotics Analysis and Outlook
9.1. North America Bifidobacterium Probiotics Revenue (USD Million) by Segments (2021-2032)
9.1.1. North America Bifidobacterium Probiotics Revenue (USD Million) by Type (2021-2032)
9.1.2. North America Bifidobacterium Probiotics Revenue (USD Million) by Application (2021-2032)
9.1.3. North America Bifidobacterium Probiotics Revenue (USD Million) by Product (2021-2032)
By Type
Liquid
Powder
By Application
Food & Beverage
Drugs
Dietary Supplements
Others
Chapter 10. Europe Bifidobacterium Probiotics Analysis and Outlook
10.1. Europe Bifidobacterium Probiotics Revenue (USD Million), by Segments (USD Million) (2021-2032)
10.1.1. Europe Bifidobacterium Probiotics Revenue (USD Million) by Type (2021-2032)
10.1.2. Europe Bifidobacterium Probiotics Revenue (USD Million) by Application (2021-2032)
10.1.3. Europe Bifidobacterium Probiotics Revenue (USD Million) by Product (2021-2032)
By Type
Liquid
Powder
By Application
Food & Beverage
Drugs
Dietary Supplements
Others
Chapter 11. Asia Pacific Bifidobacterium Probiotics Analysis and Outlook
11.1. Asia Pacific Bifidobacterium Probiotics Revenue (USD Million), and Revenue (USD Million) by Segments (2021-2032)
11.1.1. Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) by Type (2021-2032)
11.1.2. Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) by Application (2021-2032)
11.1.3. Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) by Product (2021-2032)
By Type
Liquid
Powder
By Application
Food & Beverage
Drugs
Dietary Supplements
Others
Chapter 12. South America Bifidobacterium Probiotics Analysis and Outlook
12.1. South America Bifidobacterium Probiotics Revenue (USD Million), by Segments (2021-2032)
12.1.1. South America Bifidobacterium Probiotics Revenue (USD Million) by Type (2021-2032)
12.1.2. South America Bifidobacterium Probiotics Revenue (USD Million) by Application (2021-2032)
12.1.3. South America Bifidobacterium Probiotics Revenue (USD Million) by Product (2021-2032)
By Type
Liquid
Powder
By Application
Food & Beverage
Drugs
Dietary Supplements
Others
Chapter 13. Middle East and Africa Bifidobacterium Probiotics Analysis and Outlook
13.1. Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million), by Segments (2021-2032)
13.1.1. Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) by Type (2021-2032)
13.1.2. Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) by Application (2021-2032)
13.1.3. Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) by Product (2021-2032)
By Type
Liquid
Powder
By Application
Food & Beverage
Drugs
Dietary Supplements
Others
Chapter 14. Bifidobacterium Probiotics Company Profiles
14.1 Business Overview
14.2 Product Profiles
14.3 SWOT Profiles
14.5 Recent Developments
14.6 Financial Profile
List of Companies
BioGaia
China-Biotics
Chr. Hansen
Danone S.A.
DuPont de Nemours Inc
Lallemand
Nestlé S.A.
Novozymes A/S
Probi
Yakult
15. Methodology and Data Sources
15.1 Customization Offerings
15.2 Subscription Services
15.3 Related Reports
15.4 Publisher Expertise
LIST OF TABLES
Table 1 Market Segmentation Analysis
Table 2 Global Bifidobacterium Probiotics Market Share of Leading Companies, 2023
Table 3 Product Offerings of Leading Companies
Table 4 Low Growth Scenario Forecasts
Table 5 Reference Case Growth Scenario
Table 6 High Growth Case Scenario
Table 7 Global Bifidobacterium Probiotics Revenue (USD Million) And CAGR (%) By Type (2021-2032)
Table 8 Global Bifidobacterium Probiotics Revenue (USD Million) And CAGR (%) By Application (2021-2032)
Table 9 Global Bifidobacterium Probiotics Revenue (USD Million) And CAGR (%) By Product (2021-2032)
Table 10 Global Bifidobacterium Probiotics Market Revenue (USD Million) By Regions (2021-2032)
Table 11 Global Bifidobacterium Probiotics Market Share (%) By Regions (2021-2032)
Table 12 North America Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Table 13 Europe Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Table 14 Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Table 15 South America Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Table 16 Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) By Region (2021-2032)
Table 17 North America Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Table 18 North America Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Table 19 North America Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
Table 20 Europe Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Table 21 Europe Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Table 22 Europe Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
Table 23 Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Table 24 Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Table 25 Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
Table 26 South America Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Table 27 South America Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Table 28 South America Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
Table 29 Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Table 30 Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Table 31 Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
LIST OF FIGURES
Figure 1. Market Scope
Figure 2. Pricing Forecasts Per Unit, 2023- 2032
Figure 3. Porter’s Five Forces
Figure 4. Global Bifidobacterium Probiotics Market Revenue (USD Million) By Regions (2021-2032)
Figure 5. Global Bifidobacterium Probiotics Market Share (%) By Regions (2023)
Figure 6. North America Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 7. United States Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 8. Canada Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 9. Mexico Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 10. Europe Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 11. Germany Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 12. France Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 13. United Kingdom Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 14. Spain Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 15. Italy Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 16. Russia Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 17. Rest of Europe Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 11. Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 12. China Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 13. Japan Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 14. India Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 15. South Korea Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 16. Australia Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 17. South East Asia Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 18. South America Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 19. Brazil Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 20. Argentina Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 21. Rest of Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) By Country (2021-2032)
Figure 22. Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) By Region (2021-2032)
Figure 23. Saudi Arabia Bifidobacterium Probiotics Revenue (USD Million) By Region (2021-2032)
Figure 24. The UAE Bifidobacterium Probiotics Revenue (USD Million) By Region (2021-2032)
Figure 25. Rest of Middle East Bifidobacterium Probiotics Revenue (USD Million) By Region (2021-2032)
Figure 26. South Africa Bifidobacterium Probiotics Revenue (USD Million) By Region (2021-2032)
Figure 27. Africa Bifidobacterium Probiotics Revenue (USD Million) By Region (2021-2032)
Figure 28. North America Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Figure 29. North America Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Figure 30. North America Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
Figure 31. Europe Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Figure 32. Europe Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Figure 33. Europe Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
Figure 34. Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Figure 35. Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Figure 36. Asia Pacific Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
Figure 37. South America Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Figure 38. South America Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Figure 39. South America Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
Figure 40. Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) By Type (2021-2032)
Figure 41. Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) By Application (2021-2032)
Figure 42. Middle East and Africa Bifidobacterium Probiotics Revenue (USD Million) By Product (2021-2032)
By Type
Liquid
Powder
By Application
Food & Beverage
Drugs
Dietary Supplements
Others
Countries Analyzed
North America (US, Canada, Mexico)
Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, South East Asia, Rest of Asia)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
Global Bifidobacterium Probiotics Market Size is valued at $643.2 Million in 2024 and is forecast to register a growth rate (CAGR) of 7.7% to reach $1164.3 Million by 2032.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
BioGaia, China-Biotics, Chr. Hansen, Danone S.A., DuPont de Nemours Inc, Lallemand, Nestlé S.A., Novozymes A/S, Probi, Yakult
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2032; Currency: Revenue (USD); Volume